Clinician scientists in infectious diseases must serve as leaders in the development of new strategies to effectively prevent, diagnose, and treat infection. This requires clinicians to build upon scientific advancements from varied disciplines through collaboration with basic scientists, clinical investigators, and translational researchers whose work is ?bench to bedside.? Given the current nature of post-doctoral MD research training, relatively few physicians have the interdisciplinary clinical and research training needed to conduct high quality research that address infectious diseases. Also, with the global burden of infectious disease, clinical researchers who are able to conduct basic science, clinical investigation and translational research on both the domestic and an international level is imperative. The ultimate goals of this research training program is to develop academic leaders in infectious diseases by 1) providing a dynamic, highly collaborative training environment with outstanding research opportunities, particularly for those interested in international ID; 2) providing a structured supportive training process that consistently trains research-nave physicians producing productive physician-investigators who have successfully competed for extramural funds after program graduation; and 3) promoting the academic success of physician- investigators from underrepresented groups and women, critical for the future creditability of academic medicine. We propose to achieve this goal by providing two years of integrated research experience and coursework to post-doctoral fellows in Adult Infectious Diseases at Johns Hopkins School of Medicine. The Johns Hopkins University is uniquely qualified to develop and maintain such a program given the on-going research of our faculty, the successful outcomes of our previous trainees, the resources available, and the continuous influx of bright dedicated infectious diseases physicians. The proposed training program will be unique at Johns Hopkins University because of its emphasis on the development of successful leaders in infectious diseases research.
The Johns Hopkins Division of Infectious Diseases has a strong history of over 25 years of training academics researchers, government and industry leaders, and expert hospital epidemiologists and clinicians. Continued funding will allow us to provide: a dynamic, highly collaborative training environment with outstanding research opportunities, a structured supportive training process that consistently trains research-nave physicians producing productive physician-investigators who can successfully compete for extramural funds after program graduation. Our training program promotes the academic success of physicians from underrepresented groups and women who are critically needed for the future of academic medicine and public health.
|Kendall, Emily A; Azman, Andrew S; Cobelens, Frank G et al. (2017) MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis. PLoS One 12:e0172748|
|Lienhardt, Christian; Nahid, Payam; Rich, Michael L et al. (2017) Target regimen profiles for treatment of tuberculosis: a WHO document. Eur Respir J 49:|
|Tuddenham, Susan A; Page, Kathleen R; Chaulk, Patrick et al. (2017) Patients fifty years and older attending two sexually transmitted disease clinics in Baltimore, Maryland. Int J STD AIDS 28:330-344|
|Weidner, Melissa; Mitchell, Sally; Schwarz, Kathleen (2017) Percutaneous Transhepatic Cholangioplasty to Treat Multiple Intrahepatic Biliary Strictures After Hepatoportoenterostomy. J Pediatr Gastroenterol Nutr 64:200-202|
|Kendall, Emily A; Fojo, Anthony T; Dowdy, David W (2017) Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis. Lancet Respir Med 5:191-199|
|Workneh, Meklit; Katz, Morgan J; Lamorde, Mohammed et al. (2017) Antimicrobial Resistance of Sterile Site Infections in Sub-Saharan Africa: A Systematic Review. Open Forum Infect Dis 4:ofx209|
|Kandathil, Abraham J; Breitwieser, Florian P; Sachithanandham, Jaiprasath et al. (2017) Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs. Ann Intern Med 167:1-7|
|Kendall, Emily A; Shrestha, Sourya; Cohen, Ted et al. (2017) Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model. PLoS Med 14:e1002202|
|Katz, Morgan J; Roghmann, Mary-Claire (2016) Healthcare-associated infections in the elderly: what's new. Curr Opin Infect Dis 29:388-93|
|Chida, Natasha; Shah, Maunank (2016) Infectious Diseases (ID) Learning Unit: How Rapidly to Evaluate for Active Tuberculosis Disease in Low-Prevalence Settings. Open Forum Infect Dis 3:ofw058|
Showing the most recent 10 out of 63 publications